Paragon Care Ltd (ASX: PGC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Paragon Care Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$153.61 million
P/E Ratio
9.88
Dividend Yield
6.32%
Shares Outstanding
667.87 million
Earnings per share
0.019
Dividend per share
0.01
Year To Date Return
-23.17%
Earnings Yield
10.12%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Paragon Care Ltd (ASX: PGC)
Latest News
Healthcare Shares
ASX dividend stocks: Here's a diamond in the rough I'd buy yielding more than 6%
Earnings Results
Paragon Care (ASX: PGC) share price soars 5% on $8.3 million profit
Share Market News
ASX winners and losers from the Victorian budget
Share Market News
Here's why the Paragon (ASX:PGC) share price has surged 19% today
Healthcare Shares
Why the Paragon Care share price is rocketing 83% today
Share Market News
Why these 3 ASX shares surged higher today
Share Fallers
Why ARB, OneVue, Origin Energy, & Paragon Care are tumbling lower
Share Market News
Why the Paragon share price has plummeted 19% today
Defensive Shares
3 healthcare ASX shares I'd buy for my portfolio
Growth Shares
3 ASX healthcare shares to buy for a healthy portfolio
Share Fallers
Why Bubs, Incitec Pivot, Paragon Care, & Slater & Gordon shares dropped lower today
Defensive Shares
2 ASX healthcare shares on my buy radar
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 18 Sep 2023 | $0.0060 | 100.00% | Final | 06 Oct 2023 |
| 14 Mar 2023 | $0.0060 | 100.00% | Interim | 05 Apr 2023 |
| 12 Sep 2022 | $0.0060 | 100.00% | Final | 04 Oct 2022 |
| 21 Mar 2022 | $0.0060 | 100.00% | Interim | 26 Apr 2022 |
| 13 Sep 2021 | $0.0100 | 100.00% | Final | 01 Oct 2021 |
| 21 Mar 2019 | $0.0110 | 100.00% | Interim | 26 Apr 2019 |
| 14 Sep 2018 | $0.0200 | 100.00% | Final | 12 Oct 2018 |
| 15 Mar 2018 | $0.0110 | 100.00% | Interim | 12 Apr 2018 |
| 07 Sep 2017 | $0.0000 | 100.00% | Final | 06 Oct 2017 |
| 09 Mar 2017 | $0.0110 | 100.00% | Interim | 06 Apr 2017 |
| 15 Sep 2016 | $0.0140 | 100.00% | Final | 06 Oct 2016 |
| 09 Mar 2016 | $0.0080 | 100.00% | Interim | 06 Apr 2016 |
| 08 Oct 2014 | $0.0075 | 100.00% | Final | 31 Oct 2014 |
| 07 Mar 2014 | $0.0050 | 100.00% | Interim | 31 Mar 2014 |
| 04 Oct 2013 | $0.0100 | 100.00% | Final | 31 Oct 2013 |
PGC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Paragon Care Ltd
Paragon Care Ltd is a medical device company. It is a provider of medical equipment, devices, and consumables to the healthcare market. The company provides solutions to various healthcare markets Aged care; Hospital and Acute care; Primary Care; Eye Care; Storage Solutions; and E-Health. The group is organized into four operating segments: Diagnostic and Scientific, Devices, Capital and Consumables, and Service and Technology and the majority of its revenues are generated from services and technology.
PGC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 08 Dec 2023 | $0.23 | $0.00 | 0.00% | 499,715 | $0.23 | $0.23 | $0.21 |
| 07 Dec 2023 | $0.23 | $0.00 | 0.00% | 106,619 | $0.24 | $0.24 | $0.23 |
| 06 Dec 2023 | $0.24 | $0.02 | 9.30% | 539,840 | $0.22 | $0.24 | $0.22 |
| 05 Dec 2023 | $0.22 | $0.00 | 0.00% | 674,584 | $0.22 | $0.23 | $0.21 |
| 04 Dec 2023 | $0.22 | $0.03 | 15.79% | 852,260 | $0.20 | $0.22 | $0.20 |
| 01 Dec 2023 | $0.19 | $0.00 | 0.00% | 321,432 | $0.19 | $0.20 | $0.19 |
| 30 Nov 2023 | $0.19 | $0.01 | 5.41% | 769,503 | $0.19 | $0.19 | $0.19 |
| 29 Nov 2023 | $0.19 | $0.00 | 0.00% | 621,456 | $0.19 | $0.19 | $0.18 |
| 28 Nov 2023 | $0.19 | $0.00 | 0.00% | 8,374 | $0.19 | $0.19 | $0.19 |
| 27 Nov 2023 | $0.19 | $0.01 | 5.71% | 300,145 | $0.18 | $0.19 | $0.18 |
| 24 Nov 2023 | $0.18 | $0.00 | 0.00% | 210,865 | $0.17 | $0.18 | $0.17 |
| 23 Nov 2023 | $0.17 | $0.00 | 0.00% | 355,502 | $0.18 | $0.18 | $0.17 |
| 22 Nov 2023 | $0.18 | $0.00 | 0.00% | 152,158 | $0.18 | $0.18 | $0.17 |
| 21 Nov 2023 | $0.18 | $-0.01 | -5.41% | 1,008,905 | $0.19 | $0.19 | $0.17 |
| 20 Nov 2023 | $0.19 | $0.00 | 0.00% | 131,068 | $0.18 | $0.19 | $0.18 |
| 17 Nov 2023 | $0.19 | $0.01 | 5.56% | 93,392 | $0.18 | $0.19 | $0.18 |
| 16 Nov 2023 | $0.18 | $0.01 | 5.71% | 66,741 | $0.18 | $0.18 | $0.18 |
| 15 Nov 2023 | $0.18 | $-0.01 | -5.56% | 18,833 | $0.18 | $0.18 | $0.18 |
| 14 Nov 2023 | $0.18 | $0.00 | 0.00% | 233,218 | $0.18 | $0.18 | $0.18 |
| 13 Nov 2023 | $0.18 | $0.00 | 0.00% | 65,370 | $0.18 | $0.18 | $0.18 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 21 Nov 2023 | John Walstab | Issued | 1,572,380 | $275,166 |
Issue of securities. 2,594,409 Unquoted Performance Rights
|
| 06 Oct 2023 | Shane Tanner | Buy | 49,228 | $7,499 |
Dividend Reinvestment Plan (DRP).
|
| 06 Oct 2023 | John Walstab | Buy | 100 | $15 |
Dividend Reinvestment Plan (DRP).
|
| 06 Oct 2023 | John Walstab | Buy | 4,917,418 | $749,173 |
Dividend Reinvestment Plan (DRP).
|
| 06 Oct 2023 | Geoffrey Sam | Buy | 89,460 | $13,629 |
Dividend Reinvestment Plan (DRP).
|
| 06 Oct 2023 | Brent Stewart | Buy | 140,987 | $21,479 |
Dividend Reinvestment Plan (DRP).
|
| 28 Jun 2023 | Mark Hooper | Buy | 914,347 | $201,156 |
On-market trade.
|
| 05 Apr 2023 | Mark Hooper | Issued | 1,500,000 | $382,500 |
Issue of securities. Employment Agreement
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Shane Francis Tanner | Non-Executive DirectorNon-Executive Chairman | Dec 2005 |
Mr Tanner has experience and background in the Australian healthcare industry. Shane has been integral to several small acquisitions in the business over a long period. He has also helped to establish and guide several Healthcare and Life Science businesses and he was the founding CEO of Symbion Health, one of Australia's diagnostic businesses and was the founding Chairman and led the IPO of Vitura Australia, Vision Eye Institute and Rhythm Biosciences. He is also Member of Investment and Risk Committee.
|
| Mr Philip (Phil) Nicholl | Executive Director | Nov 2019 |
Mr Nicholl is currently the CEO of one of Paragon's businesses, a company in the orthopaedics market in Australia and New Zealand. Mr Nicholl has experience in the medical devices industry having occupied senior executive roles for the companies including Stryker and Cochlear.
|
| Mr John Walstab | Chief Executive OfficerManaging Director | Feb 2022 |
Mr Walstab has over 40 years of experience in medical equipment distribution with a focus on healthcare technologies in Asia. Prior roles include Managing Director of Advanced Technology, Laboratories (Phils Medical Systems ANZ) and Business Manager for Medtel Australia. John is a member of the Australian Institute of Company Directors and sits on various Boards including Central Sydney Private Hospital, CBTR Healthcare Solutions and SMS Healthcare.
|
| Mr Geoffrey Joseph Sam | Non-Executive Director | Jun 2016 |
Mr Sam has held numerous ASX listed board positions including Chairman of Money 3, Director of Hutchinson's Childcare Services and Managing Director of Nova Health. Prior to his appointments to ASX listed companies, Geoffrey undertook numerous Chief Executive positions at Adelaide based hospitals. He is the Co-Founder and Director of Healthecare Group Pty Ltd, it comprises of 17 hospitals and Day surgeries. He is also a member of the Risk Committee.
|
| Mr Alan Timothy McCarthy | Non-Executive Director | Feb 2022 |
Mr McCarthy experience spans public health and private health services across Asia Pacific for more than 32 years, including CEO at Alpenglow, Australia and SRG NZ, MD of Philips ANZ, Vice-President Asia Pacific at CareFusion, Country Manager ANZ at Cardinal Health, and GM of Diagnostic Imaging at Mayne Health/Health Care of Australia. Currently he is a Non-Executive Director of Qscan Services Pty Ltd and RHC Group Ltd (Pacific Radiology, Auckland Radiology) and Bay Radiology and is also CEO of AdvaHealth Solutions Sg. He is Chairman of Investment Committee.
|
| Mr Brent Stewart | Non-Executive Director | May 2018 |
Mr Stewart is a company executive and director having occupied numerous senior executive and board roles over the past 25 years. He established and grew a company in Australia and New Zealand (Market Equity Pty Ltd) before selling to a multinational group (Aegis PLC). Brent has association with various segments of the healthcare sector in Australia and internationally. Currently, Brent occupies Non-Executive roles at HBF Health Ltd, Etherington Inc and Argonaut Ltd. He is Chair of Risk Committee and member of Investment Committee.
|
| Ms Claire Newstead-Sinclair | Joint Company Secretary | Aug 2022 |
-
|
| Ms Melanie Jaye Leydin | Company Secretary | Jun 2018 |
-
|
| Josephine De Martino | Chief Financial Officer |
-
|
|
| Melanie Jaye Leydin | Company Secretary |
-
|
|
| Phil Nicholl | Executive General Manager ParagonCare ANZ |
-
|
|
| Claire Newstead-Sinclair | Joint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Mr John Walstab | 124,460,317 | 18.88% |
| Pioneer Pharma Australia Pty Ltd | 53,297,068 | 8.08% |
| Citicorp Nominees Pty Limited | 34,688,468 | 5.26% |
| First Samuel Ltd Acn 086243567 (Anf Its Mda Clients A/C) | 28,703,046 | 4.35% |
| HSBC Custody Nominees (Australia) Limited | 27,859,397 | 4.23% |
| J P Morgan Nominees Australia Pty Limited | 22,319,120 | 3.39% |
| National Nominees Limited | 16,669,778 | 2.53% |
| Berne No 132 Nominees Pty Ltd (737539 A/C) | 16,567,378 | 2.51% |
| National Nominees Limited i | 16,069,332 | 2.44% |
| Mr Young Chun Kim | 10,692,000 | 1.62% |
| Mr Phillip Sidney | 10,627,809 | 1.61% |
| Realm Group Pty Limited | 7,520,575 | 1.14% |
| Bnp Paribas Noms Pty Ltd (Drp) | 5,316,943 | 0.81% |
| Jmt Investment Group Vic Pty Ltd (John Turner Super Fund A/C) | 5,000,000 | 0.76% |
| Negroni Holdings Pty Ltd (The Dfn A/C) | 4,727,531 | 0.72% |
| Mrs Sandra Joan Mcdonald & Mr Andrew Mcdonald (Mcdonald Family S/Fund A/C) | 4,502,524 | 0.68% |
| Dixson Trust Pty Limited | 4,143,800 | 0.63% |
| Jmt Investment Group Vic Pty Ltd | 4,000,000 | 0.61% |
| Mr Richard Albarran | 3,942,129 | 0.60% |
| Mr Drew Townsend | 3,942,128 | 0.60% |
